Busulfan Injection 60 mg/10 mL (6 mg/mL), For Intravenous Infusion Only, Must be diluted before use, Single Dose Vial, Sterile, Cytotoxic Agent, Rx Only, 10 mL vial, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals, Inc., Manalapan, NJ 07726, Vial NDC 72485-210-01, Carton NDC 72485-210-08.
Published December 16, 2020 · Recall initiated: December 8, 2020
Summary
FDA records drug Class II recall D-0121-2021, published December 16, 2020 and initiated December 8, 2020. Recalling firm: Shilpa Medicare Limited; Status: Terminated; Reported quantity: 2,064 vials; Lot: Lot #: 7S10008B, Exp. 12/31/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Shilpa Medicare Limited
- Distributor
- Nationwide in the U.S.
- Lot
- Lot #: 7S10008B, Exp. 12/31/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAPEMRYDI RTU (pemetrexed injection), 100 mg/10 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by: ZydusAugust 26, 2026
- FDAPEMRYDI RTU(pemetrexed injection), 500 mg/50 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by: ZydusAugust 26, 2026
- FDAImatinib Mesylate Tablets 400 mg, Rx Only, 30-count Bottle, Manufactured by: Shilpa Medicare Limited, India,December 16, 2020
- FDADocetaxel Injection USP 160 mg/8mL (20 mg/mL), For Intravenous Infusion Only, Rx Only, 8 mL Single Use Vial,December 16, 2020
- FDADexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg / 50 mL (4 mcg / mL), 50 mL Single Dose Bottle,December 16, 2020
- FDAAzacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single DoseDecember 16, 2020
Questions about this recall
Was Busulfan Injection 60 mg/10 mL (6 mg/mL), For Intravenous Infusion Only, Must be diluted before use, Single Dose Vial, Sterile, Cytotoxic Agent, Rx Only, 10 mL vial, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals, Inc., Manalapan, NJ 07726, Vial NDC 72485-210-01, Carton NDC 72485-210-08. recalled?
Yes. FDA published recall D-0121-2021 on December 16, 2020. Reported hazard: CGMP Deviations
What should I do if I have this product?
Voluntary: Firm initiated · Letter